The mechanisms by which neurons die after stroke and status epilepticus and related neuropathological conditions are unclear, but may involve voltage-dependent Na / channels, glutamate receptors, and nitric oxide ( ). These questions i NO were investigated using an in vitro primary cell culture model in which hippocampal pyramidal neurons undergo a gradual and delayed neurodegeneration induced by enhanced excitatory neurotransmission. been suggested that endogenous glutamate may mediate neuronal death in a variety of pathological conditions, including stroke and status epilepticus (2, 3). This process has come to be known as 'excitotoxicity'. Local injection of excitatory amino acid (EAA) 3 receptor agonists and stimulation of EAA afferent pathways produce a pattern of acute and chronic morphological changes in the brain similar to those found in patients with epilepsy (4, 5). Antagonists of EAA receptors possess anticonvulsant properties and prevent the morphological changes associated with seizures (6, 7). Enhanced excitatory synaptic transmission can also damage hippocampal neurons in culture via activation of N-methyl-D-aspartate (NMDA) receptors (8, 9).
SINCE THE INITIAL observation that glutamate and its analogs could kill neurons in the brain (1) , it has been suggested that endogenous glutamate may mediate neuronal death in a variety of pathological conditions, including stroke and status epilepticus (2, 3) . This process has come to be known as 'excitotoxicity'. Local injection of excitatory amino acid (EAA) 3 receptor agonists and stimulation of EAA afferent pathways produce a pattern of acute and chronic morphological changes in the brain similar to those found in patients with epilepsy (4, 5) . Antagonists of EAA receptors possess anticonvulsant properties and prevent the morphological changes associated with seizures (6, 7) . Enhanced excitatory synaptic transmission can also damage hippocampal neurons in culture via activation of N-methyl-D-aspartate (NMDA) receptors (8, 9) .
Several lines of evidence suggest that reactive oxygen species (ROS) play a pivotal role in the pathogenesis of excitotoxic death (10) . Neurotoxicity associated with overstimulation of NMDA receptors is thought to be mediated by an excessive Ca 2/ influx, leading to a series of potentially neurotoxic events (11) . One such event is the activation of nitric oxide synthase and the subsequent production of nitric oxide ( ) (12) ; another is the stimulation of phosi NO pholipase A 2 or Ca 2/ overload of mitochondria, leading to the generation of superoxide anion (O 2 · 0 ) (13) .
can react with O 2 · 0 to form peri NO oxynitrite (14) , which results in dose-dependent neuronal damage (15) .
We used primary cultures of rat hippocampus, a brain area highly vulnerable to cerebral ischemia and 1 -free/glycine-supplemented Locke's solution. Drugs were added either at this time ('simultaneous') or immediately after the cultures were returned to their original medium ('after'). Neuron survival was monitored 24 h later. Values are means { SD (three experiments). n.d., not determined.
* P õ 0.01, † P õ 0.05 vs. Mg 2/ -free alone (none).
epileptic injury, as a model to understand the roles of and relationships among Na / channels, , and i NO ROS in the neurodegenerative cascade triggered by endogenous NMDA receptor activation. In this paradigm, placing hippocampal pyramidal neurons in a Mg 2/ -free, glycine-supplemented medium for brief periods of time increases cell death considerably 24 h later (8, 9, 16) , a result of seizure-like activity (8, 9) . Not unexpectedly, cell death could be inhibited by NMDA receptor antagonists and blockers of voltage-dependent Na / channels applied either during or after removal of Mg 2/ . The cytoprotective antioxidant melatonin (17) (18) (19) and inhibitors of neuronal synthase were neuroprotective when applied afi NO ter but not during exposure to Mg 2/ -free, glycinesupplemented medium, proposing a protracted production of and ROS as participants in dei NO layed neuronal death. Astrocytes appeared to contain significant antioxidant defense stores for hippocampal neurons.
MATERIALS AND METHODS

Cell culture
Hippocampi were removed from embryonic day 18 SpragueDawley rat fetuses (Harlan, S. Pietro al Natisone, UD, Italy) and dissociated in culture medium as described (20) . Culture medium consisted of a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium supplemented to contain 2 mM glutamine, 30 mM glucose, 20 mM KCl, 1 mM sodium pyruvate, 1% heat-inactivated fetal calf serum (BIO·SPA, Wedel, Germany), N1 components (100 mg/ml transferrin, 25 mg/ml insulin, 60 mM putrescine, 20 nM progesterone, 30 nM sodium selenite) (21), 100 U/ml penicillin, and 100 mg/ml streptomycin. The cell suspension was placed in 48-well plates 9 mm in diameter (Falcon, Oxnard, Calif.) coated with 10 mg/ml poly-L-lysine (mol wt 68,000, Sigma, St. Louis, Mo.), 1 1 10 5 cells/cm 2 in 0.3 ml medium. The cultures were maintained at 37ЊC in a humidified atmosphere of 5% CO 2 -95% air. Cytosine arabinoside (5 mM) was added after 5 days to inhibit nonneuronal cell growth. Medium glucose was renewed every 7 days by adding fresh glucose to 5 mM. Cultures were used between 13 and 17 days without a change in medium.
Neurotoxicity assays
Culture-conditioned medium was removed and saved. The cultures were washed with Locke's solution (19) -free, glycine-supplemented Locke's solution in a final volume of 0.3 ml. After treatment, the hippocampal cell monolayers were washed with complete Locke's solution and returned to their original culture medium. Twenty-four hours later, cultures were fixed with 2% paraformaldehyde. Neuronal death was assessed by microscopic examination of representative fields under phase contrast optics at 2001. Cytotoxicity was evidenced by neurons that underwent disintegration in the 24 h interval after initiating treatment (8, 9, 16) . Viable pyramidal-like neurons had a soma that was phasebright and round to oval in shape, with smooth, intact neurites. Neurons were considered nonviable when they exhibited neurite fragmentation and 'beading' and when their soma exhibited swelling and vacuolation. Cell counts were made from at least five such fields in triplicate wells in three independent experiments. Control experiments showed that the loss of viable neurons assessed in this manner was proportional to the number of neurons damaged, as estimated by trypan blue staining (22) .
Materials
Culture media, N1 supplements, antibiotics, cytosine arabinoside, aminoguanidine, melatonin, N v -nitro-L-arginine (NNA), N-tert-butyl-a-phenylnitrone (PBN), and tetrodotoxin (TTX) were purchased from Sigma; 3-((RS)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) and 6,7-dinitroquinoxaline-2,3-dione (DNQX) were from Tocris Cookson Ltd. (Bristol, U.K.).
Statistical analysis
Comparisons were made by one-way analysis of variance with the Student-Newman-Keuls post hoc test for differences between groups. Differences were considered statistically significant at P õ 0.05.
RESULTS
Pharmacology of neurodegeneration
Exposure of hippocampal cell cultures, which are predominantly pyramidal neurons from this age of embryonic rodent (23) , to a Mg 2/ -free, glycine-supplemented solution for 15 min produced a considerable increase in cell death assessed 24 h later ( Table 1) . Comparable levels of cell death have been reported in earlier studies under similar culture conditions (9, 16) . This injury very likely is a consequence of enhanced excitatory neurotransmission in a Mg 2/ -free environment (24) since TTX, which blocks voltage-gated Na / channels, was protective when added either simultaneously with Mg 2/ removal or immediately after returning the cells to a Mg -free, glycine-supplemented Locke's solution (15 min) in the presence ('sim.') or absence of NNA (100 mM) and allowed to recover for 24 h in their original medium, without or with NNA (100 mM) { L-arginine (L-Arg, 1 mM) or aminoguanidine (AG, 100 mM), before culture viability was measured. Right: Cultures were exposed to Mg 2/ -free, glycine-supplemented Locke's solution (15 min) and allowed to recover for various periods of time before addition of NNA (100 mM). Culture viability was assessed after 24 h. All values are means { SD of three independent experiments (three culture wells/treatment per experiment). containing medium ( Table 1) . Activation of NMDA receptors appeared to be a key ingredient of the injury process, as competitive (CPP) and noncompetitive (MK-801) NMDA antagonists abolished cell death when added to the Mg 2/ -free incubation or immediately thereafter (Table 1) . In contrast, the selective kainate/AMPA receptor antagonist DNQX was without effect (Table 1) .
and neurodegeneration i NO
has been implicated as a mediator of excitotoxi NO icity, particularly that mediated by NMDA receptors (12) . To test for the participation of , hippocami NO pal cultures were treated with the synthase ini NO hibitor NNA (100 mM). If the inhibitor was added immediately after termination of the Mg 2/ -free incubation, a substantial degree of neuroprotection, quantitatively similar to that produced by NMDA antagonists (e.g., MK 801), was achieved (Fig. 1, left) . However, NNA was not neuroprotective if applied only during the Mg 2/ -free exposure (Fig. 1, left) . Dissociation of NNA from synthase is quite slow i NO (25) , and inhibition by NNA of the enzyme is expected to be sustained well beyond its washout from the incubation medium. Moreover, significant protection was observed when addition of the syni NO thase inhibitor was delayed for up to 4 h after concluding the Mg 2/ -free challenge (Fig. 1, right) . These findings suggest that late formation, i NO rather than that occurring during or shortly after Mg 2/ removal, was associated with neurodegeneration.
Neurodegeneration triggered by brief NMDA receptor activation could be effected by expression of the inducible form of synthase, which conceivi NO ably (e.g., through activation of gene transcription) could depend on NMDA receptor activity (26) . This possibility was tested pharmacologically because neuronal and inducible synthase isoforms are difi NO ferentially sensitive to NNA and aminoguanidine, respectively (27) (Fig. 1, left) .
Melatonin prevents death of hippocampal neurons caused by enhanced synaptic activity
toxicity may arise from inhibition of mitochoni NO drial respiration and/or reaction with O 2 · 0 to form the prooxidant species peroxynitrite, which can further degrade into a highly reactive and lipid-destroying hydroxyl or hydroxyl-like radical (14, 26) . On this basis, a protective role for ROS scavengers would be predicted in the present injury paradigm. The pineal secretory product melatonin has antioxidant effects directed to different ROS, including hydroxyl radicals (19, 28, 29) , and protects against ROS-mediated neuronal death (17, 18, 30) . In contrast to conventional antioxidants, this hormone has a proposed physiological role in neuropathological settings (31) . Addition of melatonin to hippocampal cultures in the absence of Mg 2/ did not reduce cell loss (see Fig. 3, left) . Melatonin, however, concentration-dependently (EC 50 : 19.2{2.8 mM, three independent determinations) reduced neuronal death by more than 75% when added immediately after the end of the Mg 2/ -free incubation (Fig. 2) . PBN, a chemically unrelated free radical scavenger, also limited hippocampal neuron death under Mg 2/ -free conditions when added immediately after, but not during, the period of Mg 2/ removal (Fig. 3, left) . To investigate the time window over which melatonin neuroprotection was effective, the pineal hormone (100 mM) was applied at various intervals after returning the Mg 2/ -free cultures to their original medium. Significant neuroprotection was observed when addition of melatonin was delayed for up to 4 h after exposure to Mg 2/ -free, glycine-supplemented solution, but by 6 h the effect was lost (Fig. 3, right) . -free, glycine-supplemented Locke's solution (15 min) in the presence ('sim.') or absence of either melatonin (Mel, 100 mM) or PBN (100 mM) and allowed to recover for 24 h in their original medium, without or with melatonin (100 mM) or PBN (100 mM), before culture viability was measured. Right: Cultures were exposed to Mg 2/ -free, glycine-supplemented Locke's solution (15 min) and allowed to recover for various periods of time before addition of melatonin (100 mM). Culture viability was assessed after 24 h. All values are means { SD of three independent experiments (three culture wells/ treatment per experiment 
Astroglia and the glutathione system in neuroprotection
In the central nervous system, the antioxidant glutathione (GSH) is concentrated within glial cells, and perhaps in axons and nerve terminals, but is sparse in neuronal cell bodies (33) . Glial cells have been shown to play a key role in the maintenance of neuronal GSH (34) and to protect brain neurons from oxidative stress (35) (36) (37) . We therefore explored the influence of astrocytes on hippocampal neuron injury induced by Mg 2/ removal. Neuron-astroglia cocultures were generated by omission of cytosine arabinoside from the culture medium (38) . Neuron death precipitated by brief omission of Mg 2/ was markedly reduced 24 h later in astrocyte-rich cultures ( Table 2) . Inclusion of diethyl maleate (1 mM) to bind the free sulfhydryl groups of GSH (39) during the Mg 2/ -free incubation significantly reduced the improvement in hippocampal neuron survival mediated by astrocytes (Table 2) . Diethyl maleate had little influence on neuron vitality in Mg 2/ -containing cultures, independent of the presence of astrocytes (Table 2 ). These results suggest that astrocytes act to maintain neuronal oxidant homeostasis under conditions where ROS levels become toxic. Astroglial uptake of glutamate protects cultured cortical neurons from glutamate toxicity (40) . L(-)-Threo-3-hydroxyaspartic acid, a potent inhibitor of glutamate transport, however, did not antagonize the astrocyte protective effect for hippocampal neurons exposed to a Mg . The data also provide support for a glial contribution in protecting neurons from oxidative stress.
NMDA receptor-mediated neurotoxicity may depend in part on the generation of and O 2 · 0 , i NO which react to form peroxynitrite. This form of neurotoxicity is thought to contribute to a final common pathway of injury in a wide variety of acute and chronic neurologic disorders, including focal ischemia, trauma, epilepsy, Huntington's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (42, 43) . The introduction of selective pharmacological tools and the development of transgenic knockout mice specific for the different isoforms of syni NO thase have helped to clarify the role of in excii NO totoxic brain injury (42) . participation in i NO neuronal death induced by brief NMDA exposure has been observed (44, 45) , although synthase i NO inhibitors were effective solely for the duration of the initial NMDA challenge (44) or during the postexposure period (45) . The paradigm described here, in contrast, relies on neurotoxicity precipitated by the endogenous activation of NMDA receptors, and thus more faithfully mimics the injury process linked to excessive synaptic transmission (8) . It has been reported recently that peroxynitrite and donors i NO induce neurodegeneration by eliciting autocrine exitotoxicity at NMDA receptors (46) . This finding is consistent with the current data and suggests a feedforward mechanism in which delayed neuronal death begins with Mg 2/ removal and NMDA receptor stimulation, activation of TTX-sensitive Na / channels, glutamate release, and additional NMDA receptor activation, leading ultimately to a protracted production of . A similar cycle has been proposed for i NO the delayed death of cultured striatal neurons after a brief challenge with NMDA (45).
The pineal secretory product melatonin is known to possess widespread free radical scavenging and antioxidant activities (19) and is neuroprotective in vivo and in vitro against kainic acid-induced lesions (17) , GSH depletion (18) , and ROS-mediated apoptotic death (30) . Melatonin is believed to work via electron donation to directly detoxify free radicals such as the highly toxic hydroxyl radical, which is a probable end-product of the reaction between and peri NO oxynitrite. Melatonin is also reported to scavenge peroxynitrite (47, 48) . Furthermore, melatonin limits -induced lipid peroxidation (49) and inhibits i NO cerebellar synthase (50) . Thus, the cytoproteci NO tive action of the pineal hormone in the present system could be attributed to one or several of these pathways. The kinetics of neuroprotection afforded by the delayed addition of melatonin closely mirror those for synthase inhibitors, which lends supi NO port to this premise.
Melatonin function as a free radical scavenger and antioxidant is likely facilitated by the ease with which it crosses morphophysiological barriers (e.g., the blood-brain barrier) and enters cells and subcellular compartments (19, 51) . Most studies have used pharmacological concentrations of melatonin to protect against free radical damage, although physiological levels of the indole have been shown to be beneficial in preventing the death of neuroblastoma cells exposed to the Alzheimer amyloid peptide (52) . Some evidence indicates that pinealectomy, which eliminates the nighttime rise in circulating and tissue melatonin levels, exacerbates ROS-mediated tissue damage (19) and increases brain damage after focal brain stroke and excitotoxic seizures (31) . The melatonin prevention of neurodegeneration linked to excitatory synaptic transmission is consistent with the last study. A decreased secretion of melatonin with aging has been documented (53) , which may be exaggerated in populations with dementia (54) .
The literature contains ample evidence to support a role for glial cells in antioxidant defense mechanisms (35) (36) (37) . Astrocytes limited the excitotoxic neurodegeneration induced by Mg 2/ withdrawal, and intracellular GSH-lowering agents reversed the glial protective effect. Astrocytes have a higher GSH content than neuronal cells (ref 34 ; M. Floreani, P. Giusti and S. D. Skaper, unpublished observations). GSH, which normally is present in high concentrations in the brain, functions as a major antioxidant in tissue defense against oxidative stress (55) . Glial cells influence neuronal GSH levels in culture by effectively transporting cystine from the medium and converting it to cysteine (34) . Cysteine is then released in the medium, taken up by the neurons, and used in the synthesis of GSH. A recent study suggests that the neuronal mitochondrial respiratory chain is damaged by sustained exposure to and that GSH may i NO be an important defense against such damage (56) .
